Back
SoftBank Group Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
35
SFTBF
SoftBank Group
Last Price:
59.40
Seasonality Move:
-2.05%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Sell
35
SoftBank Group (SFTBF)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBF] share price is $59.40. The Score for SFTBF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- SFTBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SFTBF Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $59.40
The current trend is moderately bearish and SFTBF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SFTBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.55 | Buy |
Relative Strength Index (14 RSI): | 49.28 | Sell |
Chaikin Money Flow: | 51 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.06 - 60.84) | Sell |
Bollinger Bands (100): | (54.54 - 65.46) | Sell |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.14 | Buy |
Relative Strength Index (14 RSI): | 81.29 | Buy |
Chaikin Money Flow: | 966983 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.36 - 56.78) | Buy |
Bollinger Bands (100): | (43.87 - 52.87) | Buy |
SFTBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.47 | Sell |
20-day SMA: | 59.86 | Sell |
50-day SMA: | 58.34 | Buy |
200-day SMA: | 57.44 | Buy |
8-day EMA: | 60.32 | Sell |
20-day EMA: | 59.82 | Sell |
50-day EMA: | 59.11 | Buy |
200-day EMA: | 56.25 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.18 | Buy |
20-day SMA: | 52.43 | Buy |
50-day SMA: | 50.91 | Buy |
200-day SMA: | 45.07 | Buy |
8-day EMA: | 58.59 | Buy |
20-day EMA: | 54.14 | Buy |
50-day EMA: | 51.2 | Buy |
200-day EMA: | 44.61 | Buy |
SoftBank Group Earnings Growth & SFTBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
SoftBank Group Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |